The Affective Properties of Synthetic Cathinones: Role of Reward and Aversion in Their Abuse

  • Heather E. KingEmail author
  • Anthony L. Riley
Part of the Current Topics in Behavioral Neurosciences book series (CTBN, volume 32)


The drug class known as synthetic cathinones has gained significant attention in the last few years as a result of increased use and abuse. These compounds have been shown to possess reinforcing efficacy in that they are abused in human populations and are self-administered in animal models. The present chapter outlines the affective properties of synthetic cathinones that are thought to impact drug self-administration in general and presents research confirming that these drugs have both rewarding and aversive effects in standalone and concurrent assessments. The implications of these affective properties for the overall abuse potential of these compounds are discussed along with directions for future research.


Affective properties Avoidance Cathinones Reward 


  1. 1.
    Baumann MH (2014) Awash in a sea of ‘bath salts’: implications for biomedical research and public health. Addiction 109(10):1577–1579CrossRefGoogle Scholar
  2. 2.
    Baumann MH, Partilla JS, Lehner KR (2013) Psychoactive “bath salts”: not so soothing. Eur J Pharmacol 698(1):1–5CrossRefGoogle Scholar
  3. 3.
    Katz DP, Bhattacharya D, Bhattacharya S, Deruiter J, Clark CR, Suppiramaniam V, Dhanasekaran M (2014) Synthetic cathinones: “a khat and mouse game”. Toxicol Lett 229(2):349–356CrossRefGoogle Scholar
  4. 4.
    Kyle PB, Iverson RB, Gajagowni RG, Spencer L (2011) Illicit bath salts: not for bathing. J Miss State Med Assoc 52(12):375–377PubMedGoogle Scholar
  5. 5.
    Baumann MH, Solis E, Watterson LR, Marusich JA, Fantegrossi WE, Wiley JL (2014) Baths salts, spice, and related designer drugs: the science behind the headlines. J Neurosci 34(46):15150–15158CrossRefGoogle Scholar
  6. 6.
    Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of “bath salts” and “legal highs”(synthetic cathinones) in the United States. Clin Toxicol 49(6):499–505CrossRefGoogle Scholar
  7. 7.
    O’Connor EC, Chapman K, Butler P, Mead AN (2011) The predictive validity of the rat self-administration model for abuse liability. Neurosci Biobehav Rev 35(3):912–938CrossRefGoogle Scholar
  8. 8.
    Sanchis‐Segura C, Spanagel R (2006) REVIEW: behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11(1):2–38CrossRefGoogle Scholar
  9. 9.
    Zernig G, Ahmed SH, Cardinal RN, Morgan D, Acquas E, Foltin RW, Stöckl P (2007) Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 80(2–3):65–119CrossRefGoogle Scholar
  10. 10.
    Weeks JR (1962) Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science 138(3537):143–144CrossRefGoogle Scholar
  11. 11.
    Ator NA, Griffiths RR (1987) Self-administration of barbiturates and benzodiazepines: a review. Pharmacol Biochem Behav 27(2):391–398CrossRefGoogle Scholar
  12. 12.
    Balster RL, Lukas SE (1985) Review of self-administration. Drug Alcohol Depend 14(3):249–261CrossRefGoogle Scholar
  13. 13.
    Fischman M (1988) Behavioral pharmacology of cocaine. J Clin Psychiatry 49:7–10PubMedGoogle Scholar
  14. 14.
    Koob G, Le Moal M (2006) Neurobiology of addiction. Elsevier, AmsterdamGoogle Scholar
  15. 15.
    Freeman KB, Riley AL (2008) The origins of conditioned taste aversion learning: a historical analysis. In: Rcilly S, Schachtman TR (eds) Conditioned taste aversions: neural and behavioral processes. Oxford university press, New York, pp 9–36Google Scholar
  16. 16.
    Davis CM, Riley AL (2010) Conditioned taste aversion learning. Ann N Y Acad Sci 1187(1):247–275CrossRefGoogle Scholar
  17. 17.
    Riley AL, Davis CM, Roma PG (2009) Strain differences in taste aversion learning: implications for animal models of drug abuse. Ann N Y Acad Sci 1187:247–275Google Scholar
  18. 18.
    Sherman JE, Roberts T, Roskam SE, Holman EW (1980) Temporal properties of the rewarding and aversive effects of amphetamine in rats. Pharmacol Biochem Behav 13(4):597–599CrossRefGoogle Scholar
  19. 19.
    Verendeev A, Riley AL (2011) Relationship between the rewarding and aversive effects of morphine and amphetamine in individual subjects. Learn Behav 39(4):399–408CrossRefGoogle Scholar
  20. 20.
    Brockwell NT, Eikelboom R, Beninger RJ (1991) Caffeine-induced place and taste conditioning: production of dose-dependent preference and aversion. Pharmacol Biochem Behav 38(3):513–517CrossRefGoogle Scholar
  21. 21.
    King HE, Riley AL (2013) A history of morphine-induced taste aversion learning fails to affect morphine-induced place preference conditioning in rats. Learn Behav 41(4):433–442CrossRefGoogle Scholar
  22. 22.
    Pomfrey RL, Bostwick TA, Wetzell BB, Riley AL (2015) Adolescent nicotine exposure fails to impact cocaine reward, aversion and self-administration in adult male rats. Pharmacol Biochem Behav 137:30–37CrossRefGoogle Scholar
  23. 23.
    Schramm-Sapyta NL, Francis R, MacDonald A, Keistler C, O’Neill L, Kuhn CM (2014) Effect of sex on ethanol consumption and conditioned taste aversion in adolescent and adult rats. Psychopharmacology 231(8):1831–1839CrossRefGoogle Scholar
  24. 24.
    Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56(6):613–672CrossRefGoogle Scholar
  25. 25.
    Tzschentke TM (2007) Review on CPP: measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12(3‐4):227–462CrossRefGoogle Scholar
  26. 26.
    Bardo M, Valone J, Bevins RA (1999) Locomotion and conditioned place preference produced by acute intravenous amphetamine: role of dopamine receptors and individual differences in amphetamine self-administration. Psychopharmacology 143(1):39–46CrossRefGoogle Scholar
  27. 27.
    Bedingfield JB, King DA, Holloway FA (1998) Cocaine and caffeine: conditioned place preference, locomotor activity, and additivity. Pharmacol Biochem Behav 61(3):291–296CrossRefGoogle Scholar
  28. 28.
    Bilsky EJ, Hui Y, Hubbell CL, Reid LD (1990) Methylenedioxymethamphetamine’s capacity to establish place preferences and modify intake of an alcoholic beverage. Pharmacol Biochem Behav 37(4):633–638CrossRefGoogle Scholar
  29. 29.
    Yates JR, Beckmann JS, Meyer AC, Bardo MT (2013) Concurrent choice for social interaction and amphetamine using conditioned place preference in rats: effects of age and housing condition. Drug Alcohol Depend 129(3):240–246CrossRefGoogle Scholar
  30. 30.
    Lisek R, Xu W, Yuvasheva E, Chiu Y-T, Reitz AB, Liu-Chen L-Y, Rawls SM (2012) Mephedrone (‘bath salt’) elicits conditioned place preference and dopamine-sensitive motor activation. Drug Alcohol Depend 126(1):257–262CrossRefGoogle Scholar
  31. 31.
    Karlsson L, Andersson M, Kronstrand R, Kugelberg FC (2014) Mephedrone, methylone and 3, 4‐methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice. Basic Clin Pharmacol Toxicol 115(5):411–416CrossRefGoogle Scholar
  32. 32.
    Cunningham CL, Gremel CM, Groblewski PA, Reilly S, Schachtman T (2009) Genetic influences on conditioned taste aversion. Oxford University Press, New YorkGoogle Scholar
  33. 33.
    Broadbent J, Muccino KJ, Cunningham CL (2002) Ethanol-induced conditioned taste aversion in 15 inbred mouse strains. Behav Neurosci 116(1):138CrossRefGoogle Scholar
  34. 34.
    Ralph RJ, Caine SB (2005) Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice. J Pharmacol Exp Ther 312(2):733–741CrossRefGoogle Scholar
  35. 35.
    Thomsen M, Caine SB (2011) Psychomotor stimulant effects of cocaine in rats and 15 mouse strains. Exp Clin Psychopharmacol 19(5):321CrossRefGoogle Scholar
  36. 36.
    King HE, Wakeford A, Taylor W, Wetzell B, Rice KC, Riley AL (2015) Sex differences in 3, 4-methylenedioxypyrovalerone (MDPV)-induced taste avoidance and place preferences. Pharmacol Biochem Behav 137:16–22CrossRefGoogle Scholar
  37. 37.
    King HE, Wetzell B, Rice KC, Riley AL (2015) An assessment of MDPV-induced place preference in adult Sprague-Dawley rats. Drug Alcohol Depend 146:116–119CrossRefGoogle Scholar
  38. 38.
    Costello N, Carlson J, Glick S, Bryda M (1989) Dose-dependent and baseline-dependent conditioning with d-amphetamine in the place conditioning paradigm. Psychopharmacology 99(2):244–247CrossRefGoogle Scholar
  39. 39.
    Durazzo TC, Gauvin DV, Goulden KL, Briscoe RJ, Holloway FA (1994) Cocaine-induced conditioned place approach in rats: the role of dose and route of administration. Pharmacol Biochem Behav 49(4):1001–1005CrossRefGoogle Scholar
  40. 40.
    Bardo M, Rowlett J, Harris M (1995) Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 19(1):39–51CrossRefGoogle Scholar
  41. 41.
    Hunt T, Amit Z (1987) Conditioned taste aversion induced by self-administered drugs: paradox revisited. Neurosci Biobehav Rev 11(1):107–130CrossRefGoogle Scholar
  42. 42.
    Verendeev A, Riley AL (2012) Conditioned taste aversion and drugs of abuse: history and interpretation. Neurosci Biobehav Rev 36(10):2193–2205CrossRefGoogle Scholar
  43. 43.
    Merluzzi AP, Hurwitz ZE, Briscione MA, Cobuzzi JL, Wetzell B, Rice KC, Riley AL (2014) Age‐dependent MDPV‐induced taste aversions and thermoregulation in adolescent and adult rats. Dev Psychobiol 56(5):943–954CrossRefGoogle Scholar
  44. 44.
    Cunningham CL, Niehus JS, Bachtold JF (1992) Ambient temperature effects on taste aversion conditioned by ethanol: contribution of ethanol‐induced hypothermia. Alcohol Clin Exp Res 16(6):1117–1124CrossRefGoogle Scholar
  45. 45.
    Doremus-Fitzwater TL, Varlinskaya EI, Spear LP (2010) Motivational systems in adolescence: possible implications for age differences in substance abuse and other risk-taking behaviors. Brain Cogn 72(1):114–123CrossRefGoogle Scholar
  46. 46.
    Spear LP (2011) Rewards, aversions and affect in adolescence: emerging convergences across laboratory animal and human data. Dev Cogn Neurosci 1(4):390–403CrossRefGoogle Scholar
  47. 47.
    Cappon GD, Morford LL, Vorhees CV (1998) Enhancement of cocaine-induced hyperthermia fails to elicit neurotoxicity. Neurotoxicol Teratol 20(5):531–535CrossRefGoogle Scholar
  48. 48.
    Dafters RI, Lynch E (1998) Persistent loss of thermoregulation in the rat induced by 3, 4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) but not by fenfluramine. Psychopharmacology 138(2):207–212CrossRefGoogle Scholar
  49. 49.
    Fukumura M, Cappon GD, Pu C, Broening HW, Vorhees CV (1998) A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein. Brain Res 806(1):1–7CrossRefGoogle Scholar
  50. 50.
    Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC (2013) In vivo effects of abused ‘bath salt’ constituent 3, 4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 38(4):563–573CrossRefGoogle Scholar
  51. 51.
    King HE, Wetzell B, Rice KC, Riley AL (2014) 3, 4-Methylenedioxypyrovalerone (MDPV)-induced conditioned taste avoidance in the F344/N and LEW rat strains. Pharmacol Biochem Behav 126:163–169CrossRefGoogle Scholar
  52. 52.
    Horan B, Smith M, Gardner EL, Lepore M, Ashby CR (1997) (—)‐nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats. Synapse 26(1):93–94CrossRefGoogle Scholar
  53. 53.
    Kosten TA, Miserendino M, Chi S, Nestler EJ (1994) Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J Pharmacol Exp Ther 269(1):137–144PubMedGoogle Scholar
  54. 54.
    Picetti R, Caccavo JA, Ho A, Kreek MJ (2012) Dose escalation and dose preference in extended-access heroin self-administration in Lewis and Fischer rats. Psychopharmacology 220(1):163–172CrossRefGoogle Scholar
  55. 55.
    Picetti R, Ho A, Butelman ER, Kreek MJ (2010) Dose preference and dose escalation in extended-access cocaine self-administration in Fischer and Lewis rats. Psychopharmacology 211(3):313–323CrossRefGoogle Scholar
  56. 56.
    Stöhr T, Wermeling DS, Weiner I, Feldon J (1998) Rat strain differences in open-field behavior and the locomotor stimulating and rewarding effects of amphetamine. Pharmacol Biochem Behav 59(4):813–818CrossRefGoogle Scholar
  57. 57.
    Davis CM, Roma PG, Dominguez JM, Riley AL (2007) Morphine-induced place conditioning in Fischer and Lewis rats: acquisition and dose-response in a fully biased procedure. Pharmacol Biochem Behav 86(3):516–523CrossRefGoogle Scholar
  58. 58.
    Riley AL (2011) The paradox of drug taking: the role of the aversive effects of drugs. Physiol Behav 103(1):69–78CrossRefGoogle Scholar
  59. 59.
    Lancellotti D, Bayer BM, Glowa JR, Houghtling RA, Riley AL (2001) Morphine-induced conditioned taste aversions in the LEW/N and F344/N rat strains. Pharmacol Biochem Behav 68(3):603–610CrossRefGoogle Scholar
  60. 60.
    Pescatore KA, Glowa JR, Riley AL (2005) Strain differences in the acquisition of nicotine-induced conditioned taste aversion. Pharmacol Biochem Behav 82(4):751–757CrossRefGoogle Scholar
  61. 61.
    Roma PG, Flint WW, Higley JD, Riley AL (2006) Assessment of the aversive and rewarding effects of alcohol in Fischer and Lewis rats. Psychopharmacology 189(2):187–199CrossRefGoogle Scholar
  62. 62.
    Glowa JR, Shaw AE, Riley AL (1994) Cocaine-induced conditioned taste aversions: comparisons between effects in LEW/N and F344/N rat strains. Psychopharmacology 114(2):229–232CrossRefGoogle Scholar
  63. 63.
    Grigson PS, Freet CS (2000) The suppressive effects of sucrose and cocaine, but not lithium chloride, are greater in Lewis than in Fischer rats: evidence for the reward comparison hypothesis. Behav Neurosci 114(2):353CrossRefGoogle Scholar
  64. 64.
    Simpson GR, Riley AL (2005) Morphine preexposure facilitates morphine place preference and attenuates morphine taste aversion. Pharmacol Biochem Behav 80(3):471–479CrossRefGoogle Scholar
  65. 65.
    Roma PG, Davis CM, Kohut SJ, Huntsberry ME, Riley AL (2008) Early maternal separation and sex differences in the aversive effects of amphetamine in adult rats. Physiol Behav 93(4):897–904CrossRefGoogle Scholar
  66. 66.
    Russo SJ, Jenab S, Fabian SJ, Festa ED, Kemen LM, Quinones-Jenab V (2003) Sex differences in the conditioned rewarding effects of cocaine. Brain Res 970(1):214–220CrossRefGoogle Scholar
  67. 67.
    Torres OV, Natividad LA, Tejeda HA, Van Weelden SA, O’Dell LE (2009) Female rats display dose-dependent differences to the rewarding and aversive effects of nicotine in an age-, hormone-, and sex-dependent manner. Psychopharmacology 206(2):303–312CrossRefGoogle Scholar
  68. 68.
    Dragoin W, Mccleary GE, McCleary P (1971) A comparison of two methods of measuring conditioned taste aversions. Behav Res Methods Instrum 3(6):309–310CrossRefGoogle Scholar
  69. 69.
    Grote FW, Brown RT (1971) Conditioned taste aversions: two-stimulus tests are more sensitive than one-stimulus tests. Behav Res Methods Instrum 3(6):311–312CrossRefGoogle Scholar
  70. 70.
    Chambers KC, Sengstake CB (1976) Sexually dimorphic extinction of a conditioned taste aversion in rats. Anim Learn Behav 4(2):181–185CrossRefGoogle Scholar
  71. 71.
    Zakharova E, Wade D, Izenwasser S (2009) Sensitivity to cocaine conditioned reward depends on sex and age. Pharmacol Biochem Behav 92(1):131–134CrossRefGoogle Scholar
  72. 72.
    Cunningham CL, Tull LE, Rindal KE, Meyer PJ (2002) Distal and proximal pre-exposure to ethanol in the place conditioning task: tolerance to aversive effect, sensitization to activating effect, but no change in rewarding effect. Psychopharmacology 160(4):414–424CrossRefGoogle Scholar
  73. 73.
    Turenne SD, Miles C, Parker LA, Siegel S (1996) Individual differences in reactivity to the rewarding/aversive properties of drugs: assessment by taste and place conditioning. Pharmacol Biochem Behav 53(3):511–516CrossRefGoogle Scholar
  74. 74.
    Ettenberg A, Fomenko V, Kaganovsky K, Shelton K, Wenzel JM (2015) On the positive and negative affective responses to cocaine and their relation to drug self-administration in rats. Psychopharmacology 232(13):2363–2375CrossRefGoogle Scholar
  75. 75.
    Horger BA, Giles MK, Schenk S (1992) Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology 107(2-3):271–276CrossRefGoogle Scholar
  76. 76.
    Horger BA, Shelton K, Schenk S (1990) Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav 37(4):707–711CrossRefGoogle Scholar
  77. 77.
    Schenk S, Partridge B (1997) Sensitization and tolerance in psychostimulant self-administration. Pharmacol Biochem Behav 57(3):543–550CrossRefGoogle Scholar
  78. 78.
    Grigson PS, Twining RC (2002) Cocaine-induced suppression of saccharin intake: a model of drug-induced devaluation of natural rewards. Behav Neurosci 116(2):321CrossRefGoogle Scholar
  79. 79.
    Cason AM, Grigson PS (2013) Prior access to a sweet is more protective against cocaine self-administration in female rats than in male rats. Physiol Behav 112:96–103CrossRefGoogle Scholar
  80. 80.
    Imperio CG, Grigson PS (2015) Greater avoidance of a heroin-paired taste cue is associated with greater escalation of heroin self-administration in rats. Behav Neurosci 129(4):380CrossRefGoogle Scholar
  81. 81.
    Twining RC, Bolan M, Grigson PS (2009) Yoked delivery of cocaine is aversive and protects against the motivation for drug in rats. Behav Neurosci 123(4):913CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 2.5 International License (, which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Authors and Affiliations

  1. 1.Psychopharmacology Laboratory, Department of PsychologyAmerican UniversityWashington, DCUSA

Personalised recommendations